First Time Loading...

Aerovate Therapeutics Inc
NASDAQ:AVTE

Watchlist Manager
Aerovate Therapeutics Inc Logo
Aerovate Therapeutics Inc
NASDAQ:AVTE
Watchlist
Price: 17.09 USD -0.23% Market Closed
Updated: May 25, 2024

Aerovate Therapeutics Inc
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aerovate Therapeutics Inc
Tax Provision Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
Aerovate Therapeutics Inc
NASDAQ:AVTE
Tax Provision
-$56k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Tax Provision
-$1.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-2%
Gilead Sciences Inc
NASDAQ:GILD
Tax Provision
-$617m
CAGR 3-Years
28%
CAGR 5-Years
23%
CAGR 10-Years
9%
Amgen Inc
NASDAQ:AMGN
Tax Provision
-$582m
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
-4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Tax Provision
-$748m
CAGR 3-Years
-13%
CAGR 5-Years
-40%
CAGR 10-Years
-56%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Tax Provision
-$184.2m
CAGR 3-Years
22%
CAGR 5-Years
-4%
CAGR 10-Years
6%

See Also

What is Aerovate Therapeutics Inc's Tax Provision?
Tax Provision
-56k USD

Based on the financial report for Dec 31, 2023, Aerovate Therapeutics Inc's Tax Provision amounts to -56k USD.

What is Aerovate Therapeutics Inc's Tax Provision growth rate?
Tax Provision CAGR 1Y
-87%

Over the last year, the Tax Provision growth was -87%.